What is NDC 72606-051?

72606-051 is the product NDC for Tocilizumab-anoh, Tocilizumab 162 mg/.9mL injection, solution, listed with the FDA by CELLTRION USA, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

CELLTRION USA, Inc., NDC labeler code 72606. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tocilizumab-anoh?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tocilizumab-anoh NDC 72606-051 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72606-051Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72606-0051Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72606-051-01	72606005101	1 SYRINGE, GLASS in 1 CARTON (72606-051-01) / .9 mL in 1 SYRINGE, GLASSMarketed from Oct 1, 2026
72606-051-04	72606005104	1 SYRINGE, GLASS in 1 CARTON (72606-051-04) / .9 mL in 1 SYRINGE, GLASSMarketed from Oct 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tocilizumab-anoh
Generic name (nonproprietary): tocilizumab-anoh
Active ingredients: Tocilizumab — 162 mg/.9mL
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: CELLTRION USA, Inc.NDC labeler code 72606
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 761498
Marketing start: Oct 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Interleukin 6 Receptor Antagonists (Mechanism)
Identifiers: Product ID 72606-051_b01afa28-11e4-47f0-9b78-bdcd8ee9e99aSPL ID b01afa28-11e4-47f0-9b78-bdcd8ee9e99a
Pharmacologic class: Interleukin-6 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472606005101 followed by a unit qualifier and the quantity

Package 72606-0051-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 72606-051

What is NDC 72606-051?: 72606-051 is the product NDC for Tocilizumab-anoh, Tocilizumab 162 mg/.9mL injection, solution, listed with the FDA by CELLTRION USA, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tocilizumab-anoh.
What is the active ingredient?: Tocilizumab.
Who is the labeler?: CELLTRION USA, Inc., NDC labeler code 72606. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tocilizumab-anoh?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under BLA 761498

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 761498
Product	Strength	Form · route	Labeler	Product NDC
Avtozmatocilizumab	Tocilizumab 162 mg/.9mL	Injection, SolutionSubcutaneous	CELLTRION USA, Inc.	72606-045